This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lohmann, D. Articles by Hofler, H. Search for Related Content PubMed PubMed Citation Articles by Lohmann, D. Articles by Hofler, H.

American Journal of Pathology, Vol 142, 907-915, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data

D Lohmann, B Putz, U Reich, J Bohm, H Prauer and H Hofler
Institute of Pathology, Technical University of Munich, Germany.

The spectrum of p53 gene mutations was determined in formalin-fixed, paraffin-embedded samples of small-cell lung cancer derived from 28 patients. By direct sequencing of exons 5, 7, and 8, including their flanking intron sequences, 18 mutations were identified in 17 tumors (61%), and in all but two of these the wild type allele was lost. In 8 cases, the mutation detected in the tumor was absent from the corresponding normal tissue, indicating that these mutations were somatically acquired. In two patients, identical mutations were found in the primary tumor and corresponding metastases. In a further case, an intrapulmonary metastasis did not show the mutation detected in the primary tumor. The local distribution of the mutations resembled that reported in non-small cell lung cancer and gave no indication of distinct bot spot regions. G-to-T transversions were the predominant type of mutation, reflecting a possible genotoxic influence of carcinogens contained in tobacco smoke. Mutations were equally distributed among tumors with intermediate and oat cell histology and did not show a significant association to age and gender of the patients. Also, no significant relationship was observed between the presence of a mutation and tumor stage (T, N, M) or survival. However, transitions at CpG dinucleotides were restricted to tumors without detectable metastases at the time of biopsy, whereas all other mutations occurred in metastasizing small cell lung cancer.

This article has been cited by other articles:

				E. Steels, M. Paesmans, T. Berghmans, F. Branle, F. Lemaitre, C. Mascaux, A.P. Meert, F. Vallot, J.J. Lafitte, and J.P. Sculier Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur. Respir. J., October 1, 2001; 18(4): 705 - 719. [Abstract] [Full Text] [PDF]

				J. E. Tseng, M. Rodriguez, J. Ro, D. Liu, W. K. Hong, and L. Mao Gender Differences in p53 Mutational Status in Small Cell Lung Cancer Cancer Res., November 1, 1999; 59(22): 5666 - 5670. [Abstract] [Full Text] [PDF]